Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.

Could Skibidi Toilet, the bizarre animated YouTube series that gets more views than the NBA on the site, become the next ...

Now, the China Spallation Neutron Source — a major national scientific facility in Dongguan, Guangdong province — has ...

Studio head Philip Holt reveals the 2020 Xbox Showcase trailer was made by just 4-5 people when the game existed only as a Word document. Alpha testing starts May with real gameplay finally coming ...

The acquisition will provide access to the half-life extended, high-affinity anti-IgE antibody, Exl-111.

Viridian Therapeutics (VRDN) remains a 'Sell' as both lead TED assets underperform versus Amgen’s Tepezza, with limited ...

Researchers analyzed human, mouse, and clinical trial data and found PAM gene variants caused GLP‑1 resistance. The variants reduced the efficacy of GLP‑1 receptor agonists for blood glucose control.< ...

The moment nuclear material is produced, processed or purified, it sets off a hidden countdown, marked by the half-life of ...

A new study reveals that popular diabetes and weight-loss drugs like Ozempic and Wegovy may not work as effectively for about ...

Historically good results with IL-4 inhibitors raise questions with U.S. audience ...

Convergent Therapeutics' Dr. Philip Kantoff and Plus Therapeutics' Dr. Marc Hedrick discuss how unmet medical needs, maturing ...